These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 10025826)

  • 1. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
    Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
    J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
    Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
    J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Suzuki T; Kurabayashi M
    Chest; 2002 Aug; 122(2):542-8. PubMed ID: 12171829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
    Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
    Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2002 Oct; 43(10):1279-85. PubMed ID: 12368364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.
    Merlet P; Benvenuti C; Moyse D; Pouillart F; Dubois-Randé JL; Duval AM; Loisance D; Castaigne A; Syrota A
    J Nucl Med; 1999 Jun; 40(6):917-23. PubMed ID: 10452306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
    Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
    J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
    Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
    J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2003 Feb; 41(4):574-81. PubMed ID: 12598068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.
    Fukuoka S; Hayashida K; Hirose Y; Shimotsu Y; Ishida Y; Kakuchi H; Eto T
    Eur J Nucl Med; 1997 May; 24(5):523-9. PubMed ID: 9142733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
    Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Nakata S; Shigematsu Y
    Circ J; 2002 Dec; 66(12):1139-43. PubMed ID: 12499621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
    Pace L; Betocchi S; Losi MA; Della Morte AM; Ciampi Q; Nugnez R; Chiariello M; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):20-5. PubMed ID: 15195000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of 201Tl/123I MIBG (metaiodobenzylguanidine) mismatched myocardial regions for predicting ventricular tachycardia in patients with idiopathic dilated cardiomyopathy].
    Maeno M; Ishida Y; Shimonagata T; Hayashida K; Toyama T; Hirose Y; Nagata M; Miyatake K; Uehara T; Nishimura T
    Kaku Igaku; 1993 Oct; 30(10):1221-9. PubMed ID: 8264112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.